Ballentine Partners, LLC

Position in RPRX — Royalty Pharma plc

CIK 1374889 Waltham, MA

Position in RPRX

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$506,143

+$47,550 QoQ

Shares Held

9,027

-5.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#21

of 54 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Ballentine Partners, LLC holds $12,066,429 across 29 Biotechnology names. RPRX ranks #7 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	5,245	$2,605,347
2	KRYS	Krystal Biotech, Inc.	2,138	$794,629
3	ARGX	Argenx SE	772	$716,237
4	REGN	Regeneron Pharmaceuticals, Inc.	1,054	$657,210
5	INCY	Incyte Corp	4,816	$545,940
6	ALNY	Alnylam Pharmaceuticals, Inc.	1,695	$510,244
7	RPRX	Royalty Pharma plc This page	9,027	$506,143
8	HALO	Halozyme Therapeutics, Inc.	6,331	$495,526

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$506,143	9,027	-5.6%	Shares	Other	2026-07-17
2026-03-31	$458,593	9,560	-8.4%	Shares	Other	2026-05-14
2025-12-31	$403,478	10,442	+0.7%	Shares	Other	2026-02-03
2025-09-30	$365,747	10,367	-3.4%	Shares	Other	2025-11-03
2025-06-30	$386,565	10,729	+38.0%	Shares	Other	2025-07-15
2025-03-31	$242,004	7,774	-0.9%	Shares	Other	2025-05-01
2024-12-31	$200,151	7,846	-37.4%	Shares	Other	2025-01-16
2024-03-31	$380,870	12,541	+3.3%	Shares	Other	2024-04-11
2023-12-31	$340,872	12,135	-6.2%	Shares	Other	2024-01-23
2022-03-31	$503,830	12,932	+41.9%	Shares	Sole	2022-05-05
2021-12-31	$363,153	9,113	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.